Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger–Ellison syndrome

This publication has 35 references indexed in Scilit:

• Equipotent inhibition of gastric acid secretion by equal doses of oral or intravenous pantoprazole
  Alimentary Pharmacology & Therapeutics, 1998
• Lack of pharmacokinetic interaction of pantoprazole with diazepam in man
  British Journal of Clinical Pharmacology, 1996
• Zollinger-Ellison Syndrome
  Drugs, 1996
• Similarities and Differences in the Properties of Substituted Benzimidazoles: A Comparison between Pantoprazole and Related Compounds
  Digestion, 1995
• Parenteral control of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome
  Digestive Diseases and Sciences, 1993
• Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndrome
  Digestive Diseases and Sciences, 1993
• (H+, K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 4. A novel series of dimethoxypyridyl-substituted inhibitors with enhanced selectivity. The selection of pantoprazole as a clinical candidate
  Journal of Medicinal Chemistry, 1992
• Use of omeprazole in patients with Zollinger-Ellison syndrome
  Digestive Diseases and Sciences, 1991
• Single intravenous administration of the H⁺, K⁺‐ATPase inhibitor BY 1023/SK&F 96022—inhibition of pentagastrin‐stimulated gastric acid secretion and pharmacokinetics in man
  Alimentary Pharmacology & Therapeutics, 1990
• Effect of single and repeated intravenous doses of omeprazole on pentagastrin stimulated gastric acid secretion and pharmacokinetics in man.
  Gut, 1988